PubRank

Platelet Aggregation in Patients With Coronary Artery Disease and Kidney Dysfunction Taking Clopidogrel or Ticagrelor

Clinical Trial ID NCT03039205

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT03039205

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999 82.86
2 Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002 20.22
3 Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2009 18.03
4 Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004 9.13
5 Effects of antiplatelet therapy on mortality and cardiovascular and bleeding outcomes in persons with chronic kidney disease: a systematic review and meta-analysis. Ann Intern Med 2012 3.78
6 Influence of concurrent renal dysfunction on outcomes of patients with acute coronary syndromes and implications of the use of glycoprotein IIb/IIIa inhibitors. J Am Coll Cardiol 2003 2.99
7 Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study. Circulation 2009 2.84
8 Assessment of ADP-induced platelet aggregation with light transmission aggregometry and multiple electrode platelet aggregometry before and after clopidogrel treatment. Thromb Haemost 2008 2.46
9 The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease. J Am Coll Cardiol 2004 2.32
10 The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 2002 2.03
11 Use of evidence-based therapies in short-term outcomes of ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction in patients with chronic kidney disease: a report from the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network registry. Circulation 2010 2.02
12 Ticagrelor versus clopidogrel in acute coronary syndromes in relation to renal function: results from the Platelet Inhibition and Patient Outcomes (PLATO) trial. Circulation 2010 1.96
13 Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation 2002 1.88
14 Safety and efficacy of antiplatelet and antithrombotic therapy in acute coronary syndrome patients with chronic kidney disease. J Am Coll Cardiol 2011 1.43
15 Inhibitory effects of ticagrelor compared with clopidogrel on platelet function in patients with acute coronary syndromes: the PLATO (PLATelet inhibition and patient Outcomes) PLATELET substudy. J Am Coll Cardiol 2010 1.26
16 A comparison of clopidogrel responsiveness in patients with versus without chronic renal failure. Am J Cardiol 2009 0.94
17 Ticagrelor induces adenosine triphosphate release from human red blood cells. Biochem Biophys Res Commun 2012 0.83
18 Pharmacokinetics, pharmacodynamics, and safety of ticagrelor in volunteers with severe renal impairment. J Clin Pharmacol 2011 0.82
19 Ticagrelor in the renal dysfunction subgroup: subjugated or substantiated? Circulation 2010 0.75
20 Antiplatelet agents for chronic kidney disease. Cochrane Database Syst Rev 2022 0.75
Next 100